# Sequential Intravesical Bacillus Calmette-Guérin and Electromotive Mitomycin-C After Transuretheral Resection

> **NCT02202044** · NA · TERMINATED · sponsor: **University of Colorado, Denver** · enrollment: 13 (actual)

## Conditions studied

- Bladder Carcinoma

## Interventions

- **DEVICE:** Intravesical BCG and EMDA/MMC

## Key facts

- **NCT ID:** NCT02202044
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-02-24
- **Primary completion:** 2016-05-11
- **Final completion:** 2016-05-11
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** The institution was requiring extensive changes to the protocol
- **Last updated:** 2019-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02202044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02202044, "Sequential Intravesical Bacillus Calmette-Guérin and Electromotive Mitomycin-C After Transuretheral Resection". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02202044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*